2 November 2020
The Narcotic Drugs Regulation 2016 prescribes fees for various applications relating to medicinal cannabis made under the Narcotic Drugs Act 1967
2 November 2020
On 1 November 2020 cost recovery arrangements for the Medicinal Cannabis Scheme in the Narcotic Drugs Act 1967 will change to introduce fees and charges for cannabis-related manufacture licences and permits granted under the Scheme.
2 November 2020
Summary of fees and charges arising from the Australian Narcotic Drugs legislation and associated regulations
7 October 2020
The Australian Government will implement a second phase of the pilot program to increase the amount of kava allowed to be imported in Australia.
16 September 2020
Guideline to assist licence applicants and holders in designing and meeting security standards that are required for the cultivation, production and manufacture of medicinal cannabis
27 July 2020
This guidance is for stakeholders who are applying for a new licence under the Narcotic Drugs Act 1967 to cultivate, produce and/or manufacture cannabis or cannabis material for the purposes of patient supply or research using downloadable flat forms
21 April 2020
Update to guidance on Sponsored Import and Supply of Unregistered Medicinal Cannabis Products
7 April 2020
Provides information on how the Office of Drug Control implements cost recovery for regulatory activities associated with the direct costs of processing licence and permit applications for the cultivation of medicinal cannabis and the ongoing monitoring and compliance of the regulatory scheme
16 January 2020
Our plan for how HPRG will maintain and build its regulatory science capability over the next 5 years
2 January 2020
Guideline to assist licence applicants and holders to assess whether they are fit and proper to hold a licence to cultivate, produce or manufacture under the Narcotic Drugs Act 1967
2 January 2020
Guideline to assist licence applicants and holders in designing and meeting standards required for record keeping and reporting matters related to cultivation, production and manufacture of medicinal cannabis
2 January 2020
The Office of Drug Control is the regulatory body responsible for licensing cultivation and production of cannabis for medicinal purposes
2 January 2020
Further information on medicinal cannabis manufacture licences and permit applications
20 September 2019
Guidance for completing import/export licence applications for narcotic, psychotropic and precursor substances
14 May 2019
Information on how ODC implements cost recovery for regulatory activities - 2018-19
10 April 2018
Guidance for cultivators and manufacturers of medicinal cannabis